NOTA:FRA
Novartis
144,00 €
arrow_downward
−0,69%(−1,00) 1D
18. nov., 22:00:00 GMT +1 · EUR
search
Vsi simboli
| Simbol | Cena | Sprememba | Odstotna sprememba |
|---|
insights_autoGeneriranje najpomembnejših vpogledov za NOTA …
Odpri
144,00 €
Visoka
144,00 €
Nizka
144,00 €
Tržna kapitalizacija
314,68 mrd.
Povprečni promet
8,00
Promet
0,00
52-tedenski najvišji tečaj
146,00 €
52-tedenski najnižji tečaj
105,50 €
Št. zaposlenih
75 tis.
Odpri
144,00 €
Visoka
144,00 €
Nizka
144,00 €
Tržna kapitalizacija
314,68 mrd.
Povprečni promet
8,00
Promet
0,00
52-tedenski najvišji tečaj
146,00 €
52-tedenski najnižji tečaj
105,50 €
Št. zaposlenih
75 tis.
Novice
Iz spletnih virov in novičarskih partnerjev
Benzinga
·
pred 12 urami
Here’s How Much You Would Have Made Owning Novartis Stock In The Last 5 Years
Zacks Investment Research
·
pred 13 urami
NVS Gets FDA Nod for Cosentyx in Adults With Polymyalgia Rheumatica
marketscreener.com
·
pred 1 dnevom
Swiss Market Index Retreats Amid Tech Selloff; Novartis Shares Down
Profil
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others.
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes.
After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
Vizitka: Novartis
Generalni direktorVasant Narasimhan
Št. zaposlenih75,3 tis.
Ustanovljeno7. mar. 1996
SedežBasel, Basel, Švica
SektorHealth Care
Panoga-
Spletno mestonovartis.com